Trupanion (NASDAQ:TRUP – Free Report) had its price objective trimmed by Stifel Nicolaus from $44.00 to $41.00 in a research note published on Thursday,Benzinga reports. The firm currently has a hold rating on the financial services provider’s stock.
A number of other research firms have also weighed in on TRUP. Piper Sandler reduced their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday. Northland Securities upped their price objective on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $46.60.
View Our Latest Research Report on TRUP
Trupanion Price Performance
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The company had revenue of $337.31 million for the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. Research analysts anticipate that Trupanion will post 0.13 EPS for the current fiscal year.
Insider Activity
In related news, CFO Fawwad Qureshi sold 9,867 shares of Trupanion stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $53.08, for a total transaction of $523,740.36. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Emily Dreyer sold 900 shares of Trupanion stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $54.55, for a total value of $49,095.00. Following the transaction, the senior vice president now directly owns 23,808 shares in the company, valued at approximately $1,298,726.40. The trade was a 3.64 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 11,581 shares of company stock worth $615,159 over the last quarter. 5.50% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its position in Trupanion by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider’s stock worth $173,362,000 after purchasing an additional 45,653 shares during the last quarter. Wellington Management Group LLP lifted its position in shares of Trupanion by 4.4% during the 3rd quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock valued at $142,475,000 after buying an additional 142,156 shares during the last quarter. FMR LLC lifted its position in shares of Trupanion by 55,963.7% during the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after buying an additional 1,170,202 shares during the last quarter. Marshall Wace LLP lifted its position in shares of Trupanion by 6.9% during the 4th quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider’s stock valued at $43,459,000 after buying an additional 57,804 shares during the last quarter. Finally, Balyasny Asset Management L.P. lifted its position in shares of Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock valued at $40,548,000 after buying an additional 661,559 shares during the last quarter.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More
- Five stocks we like better than Trupanion
- Following Congress Stock Trades
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- DuPont’s Electronics Spinoff: The Start of Something Big
- What is a Death Cross in Stocks?
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.